Ringpu Bio-Technology shareholder stakes rise after share buyback
Tianjin Ringpu Bio-Technology completed the cancellation of 1,093,200 restricted shares from its 2022 incentive plan, reducing total share capital from 465,847,906 shares to 464,754,706 shares.
The share reduction caused controlling shareholder Li Shoujun and concerted party Li Rui's stake to passively increase from 35.95% to 36.04%.
Major shareholder Liang Wu plans to transfer 900,000 shares to concerted parties via block trades while maintaining their combined 7.00% stake.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Supplementary Source Documents
News Alerts
Get instant email alerts when Tianjin Ringpu Bio-Technology publishes news
Free account required • Unsubscribe anytime